spacer
home > ict > summer 2019 > plan, track, and refine
PUBLICATIONS
International Clinical Trials

Plan, Track, and Refine




‘Eating healthy is easy’. This is a sentiment you are unlikely to hear from someone who is trying to change their eating habits. For most people, eating healthy requires a plan, the discipline, and the willingness to adapt to changing circumstances. Put simply, a great deal of thought and effort are required to see real and consistent results. Similarly, ‘managing enrolment is easy’ is not something you are likely to hear from a sponsor who has had issues in the past or is heading into a new therapeutic area. Much like eating healthy, enrolment requires sponsors and CROs to develop, track, and continually refine a plan to hit their targets and ensure the health of their trial.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Mark Springer has over 20 years of clinical operations expertise, with a focus on trial and project management and recruitment and retention enhancements, as well as driving the adoption of new innovation through change management. Within the Consultative Services group, Mark is the lead Subject Matter Expert for the trial optimiser services, which includes StudyOptimizer. Together, these are tools that help study teams plan, track, diagnose, and optimise patient enrolment.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Kindeva Drug Delivery, Formerly 3M Drug Delivery Systems, Launches as an Independent Company

Kindeva is a leading global contract development and manufacturing organization (CDMO) that specializes in solving complex drug delivery challenges for its pharmaceutical and biotechnology customers. With approximately 900 employees, Kindeva serves customers with a wealth of expertise in formulation, product development and manufacturing. Kindeva-developed and manufactured therapies treat patients battling a host of debilitating and chronic diseases, including respiratory illnesses and cardiovascular conditions. The company's microneedle-based drug delivery platforms are currently being utilized in dozens of development programs, including programs for osteoporosis, immunotherapies, COVID-19 vaccines, and other difficult-to-deliver therapies.
More info >>

White Papers
 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement